Biotechnology Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia August 6, 2020
Biotechnology Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients August 6, 2020
Health Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases August 6, 2020
Biotechnology Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020 August 6, 2020
Search
biotech investing
